Actively Recruiting
Clinical Effect of LG Medipain for Managing Chronic Pain Disorders
Led by Jeeyoun Moon · Updated on 2024-05-29
90
Participants Needed
1
Research Sites
158 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Scrambler Therapy is a type of non-invasive neuromodulation. According to the researches that studied the effects of the existing Scrambler therapy, 10 times of Scrambler Therapy showed a significant pain relief lasting for more than 1-3 months in various pain disorders such as post-herpetic neuralgia, cancer-related neuropathic pain, and mixed pain. No treatment-related side effects have been reported in Scrambler therapy conducted in previous studies. The most inconvenient thing about Scrambler Therapy is that it has to be treated more than 10 times during specific period, so frequent visits to the hospital for treatment linked to the higher burden for the patient's cost and even those are not fully covered by the government's insurance. To reduce this discomfort and expand the range of treatment in the era of Corona of untact treatment, LG Electronics devised a home self-scrambler treatment device for pain patients. The LG Medipain device has the same treatment function as the existing hospital Scrambler treatment device, but there has been no study on its efficacy and safety. Therefore, the investigators want to conduct this research and find out about the safety and equal efficiency of the LG Medipain Therapy. In this study, it is expected that pain relief and improvement of quality of life can be obtained for patients with various types of chronic pain through self-application of LG Medipain device.
CONDITIONS
Official Title
Clinical Effect of LG Medipain for Managing Chronic Pain Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 19 years or older with chronic pain lasting more than 3 months
- Pain score of 4 or higher on the 11-point Numeric Rating Scale on the day of admission
- Stable use of oral pain medications of the same type and dose for at least 1 month before and during the study
- Voluntary written consent to participate in the study
- Agreement in writing to return the Scrambler Therapy device
- Diagnosis of nociceptive pain (joint pain, myofascial pain syndrome), neuropathic pain (postherpetic neuralgia, peripheral nerve injury, nerve entrapment syndrome), or mixed pain
You will not qualify if you...
- Patient refusal to participate
- Lack of pain relief from previous Scrambler Therapy
- Currently receiving Scrambler Therapy at outpatient pain clinics
- Use of Scrambler Therapy within 6 months before participation
- Systemic or local infection near the treatment area
- Cognitive decline preventing understanding of pain rating, questionnaires, or self-treatment
- Inability to self-administer 10 treatments over 2 weeks
- Pregnancy
- Implantation of pacemaker, brain stimulator, or similar device
- Any other condition deemed unsuitable by investigators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Hospital
Seoul, South Korea, 110-744
Actively Recruiting
Research Team
J
Jee Yoon Moon, Pf
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here